Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Methods of economic evaluation for the German Statutory Healthcare System.

× No keyword cloud information.

6 in total

Review 1. Health economic guidelines--similarities, differences and some implications.

Authors: J Hjelmgren; F Berggren; F Andersson
Journal: Value Health Date: 2001 May-Jun Impact factor: 5.725

2. One hundred and eighteen years of the German health insurance system: are there any lessons for middle- and low-income countries?

Authors: Till Bärnighausen; Rainer Sauerborn
Journal: Soc Sci Med Date: 2002-05 Impact factor: 4.634

3. Economic analysis of health technologies and programmes. A Spanish proposal for methodological standardisation.

Authors: J Rovira; F Antoñanzas
Journal: Pharmacoeconomics Date: 1995-09 Impact factor: 4.981

4. An end to Germany's bureaucratic nightmare?

Authors: Robert Hyde
Journal: Lancet Date: 2006-05-27 Impact factor: 79.321

Review 5. Methods for determining cost-benefit ratios for pharmaceuticals in Germany.

Authors: J- Matthias Graf von der Schulenburg; Christoph Vauth; Thomas Mittendorf; Wolfgang Greiner
Journal: Eur J Health Econ Date: 2007-09

6. [Comments by the Working Group for Methods of Economic Evaluation in Health Care (AG MEG) to IQWiG's Draft Guidelines "Methods for Assessment of the Relation of Benefits to Costs in the German Statutory Health Care System"].

Authors: C Krauth; J John; P Aidelsburger; B Brüggenjürgen; T Hansmeier; F Hessel; T Kohlmann; J Moock; H Rothgang; B Schweikert; R Seitz; J Wasem
Journal: Gesundheitswesen Date: 2008-06

6 in total

2 in total

1. Methods of economic evaluation for the German statutory healthcare system.

Authors: J Jaime Caro
Journal: Pharmacoeconomics Date: 2009 Impact factor: 4.981

2. Methods of economic evaluation for the German statutory healthcare system.

Authors: Thomas Mittendorf; Wolfgang Greiner; Johann-Matthias von der Schulenburg
Journal: Pharmacoeconomics Date: 2009 Impact factor: 4.981

2 in total